Below are the most recent publications written about "Hyperlipidemias" by people in Profiles.
-
Hulme OL, Khurshid S, Weng LC, Anderson CD, Wang EY, Ashburner JM, Ko D, McManus DD, Benjamin EJ, Ellinor PT, Trinquart L, Lubitz SA. Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records. JACC Clin Electrophysiol. 2019 11; 5(11):1331-1341.
-
Liu Q, Matthan NR, Manson JE, Howard BV, Tinker LF, Neuhouser ML, Van Horn LV, Rossouw JE, Allison MA, Martin LW, Li W, Snetselaar LG, Wang L, Lichtenstein AH, Eaton CB. Plasma Phospholipid Fatty Acids and Coronary Heart Disease Risk: A Matched Case-Control Study within the Women's Health Initiative Observational Study. Nutrients. 2019 Jul 21; 11(7).
-
Pappas DA, Nyberg F, Kremer JM, Lampl K, Reed GW, Horne L, Ho M, Onofrei A, Malaviya AN, Rillo OL, Radominski SC, Gal J, Gibofsky A, Popkova TV, Laurindo L, Kerzberg EM, Zahora R, Pons-Estel BA, Curtis JR, Furst DE, Greenberg JD. Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. Clin Rheumatol. 2018 Sep; 37(9):2331-2340.
-
Turner PL, Barry KA. Alirocumab (Praluent) for Treatment of Hyperlipidemia. Am Fam Physician. 2016 Aug 15; 94(4):310-1.
-
Abelson JS, Afaneh C, Dolan P, Chartrand G, Dakin G, Pomp A. Laparoscopic Sleeve Gastrectomy: Co-morbidity Profiles and Intermediate-Term Outcomes. Obes Surg. 2016 08; 26(8):1788-93.
-
Schreiner PJ, Jacobs DR, Wong ND, Kiefe CI. Twenty-Five Year Secular Trends in Lipids and Modifiable Risk Factors in a Population-Based Biracial Cohort: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2011. J Am Heart Assoc. 2016 07 05; 5(7).
-
Bauer RC, Sasaki M, Cohen DM, Cui J, Smith MA, Yenilmez BO, Steger DJ, Rader DJ. Tribbles-1 regulates hepatic lipogenesis through posttranscriptional regulation of C/EBPa. J Clin Invest. 2015 Oct 01; 125(10):3809-18.
-
Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, Vaes N, Olde Damink SW, Verheyen F, Koek GH, L?tjohann D, Grebe A, Latz E, Shiri-Sverdlov R. Weekly Treatment of 2-Hydroxypropyl-?-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice. Int J Mol Sci. 2015 Sep 02; 16(9):21056-69.
-
Qureshi WT, Keteyian SJ, Brawner CA, Dardari Z, Blaha MJ, Al-Mallah MH. Impact of statin use on cardiorespiratory fitness in multi-racial men and women: The Henry Ford Exercise Testing (FIT) Project. Int J Cardiol. 2015 Oct 15; 197:76-7.
-
Juraschek SP, Blaha MJ, Blumenthal RS, Brawner C, Qureshi W, Keteyian SJ, Schairer J, Ehrman JK, Al-Mallah MH. Cardiorespiratory fitness and incident diabetes: the FIT (Henry Ford ExercIse Testing) project. Diabetes Care. 2015 Jun; 38(6):1075-81.